BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29277937)

  • 1. Effects of Y361-auto-phosphorylation on structural plasticity of the HIPK2 kinase domain.
    Scaglione A; Monteonofrio L; Parisi G; Cecchetti C; Siepi F; Rinaldo C; Giorgi A; Verzili D; Zamparelli C; Savino C; Soddu S; Vallone B; Montemiglio LC
    Protein Sci; 2018 Mar; 27(3):725-737. PubMed ID: 29277937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIPK2 kinase activity depends on cis-autophosphorylation of its activation loop.
    Saul VV; de la Vega L; Milanovic M; Krüger M; Braun T; Fritz-Wolf K; Becker K; Schmitz ML
    J Mol Cell Biol; 2013 Feb; 5(1):27-38. PubMed ID: 23000554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIPK2 catalytic activity and subcellular localization are regulated by activation-loop Y354 autophosphorylation.
    Siepi F; Gatti V; Camerini S; Crescenzi M; Soddu S
    Biochim Biophys Acta; 2013 Jun; 1833(6):1443-53. PubMed ID: 23485397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of tyrosine autophosphorylation on catalytic activity and subcellular localisation of homeodomain-interacting protein kinases (HIPK).
    van der Laden J; Soppa U; Becker W
    Cell Commun Signal; 2015 Jan; 13():3. PubMed ID: 25630557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Tyrosine Kinase c-Abl Promotes Homeodomain-interacting Protein Kinase 2 (HIPK2) Accumulation and Activation in Response to DNA Damage.
    Reuven N; Adler J; Porat Z; Polonio-Vallon T; Hofmann TG; Shaul Y
    J Biol Chem; 2015 Jul; 290(27):16478-88. PubMed ID: 25944899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The crystal structure of the protein kinase HIPK2 reveals a unique architecture of its CMGC-insert region.
    Agnew C; Liu L; Liu S; Xu W; You L; Yeung W; Kannan N; Jablons D; Jura N
    J Biol Chem; 2019 Sep; 294(37):13545-13559. PubMed ID: 31341017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of dual specificity kinase activity of DYRK1A.
    Walte A; Rüben K; Birner-Gruenberger R; Preisinger C; Bamberg-Lemper S; Hilz N; Bracher F; Becker W
    FEBS J; 2013 Sep; 280(18):4495-511. PubMed ID: 23809146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential interactions of the homeodomain-interacting protein kinase 2 (HIPK2) by phosphorylation-dependent sumoylation.
    Sung KS; Go YY; Ahn JH; Kim YH; Kim Y; Choi CY
    FEBS Lett; 2005 Jun; 579(14):3001-8. PubMed ID: 15896780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Covalent modification of human homeodomain interacting protein kinase 2 by SUMO-1 at lysine 25 affects its stability.
    Gresko E; Möller A; Roscic A; Schmitz ML
    Biochem Biophys Res Commun; 2005 Apr; 329(4):1293-9. PubMed ID: 15766567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIPK2-T566 autophosphorylation diversely contributes to UV- and doxorubicin-induced HIPK2 activation.
    Verdina A; Di Rocco G; Virdia I; Monteonofrio L; Gatti V; Policicchio E; Bruselles A; Tartaglia M; Soddu S
    Oncotarget; 2017 Mar; 8(10):16744-16754. PubMed ID: 28060750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of protein kinase HIPK2 is subject to a quality control mechanism that acts during translation and requires its kinase activity to prevent degradation of nascent HIPK2.
    Müller JP; Scholl S; Kunick C; Klempnauer KH
    Biochim Biophys Acta Mol Cell Res; 2021 Jan; 1868(1):118894. PubMed ID: 33091504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. US11 of herpes simplex virus type 1 interacts with HIPK2 and antagonizes HIPK2-induced cell growth arrest.
    Giraud S; Diaz-Latoud C; Hacot S; Textoris J; Bourette RP; Diaz JJ
    J Virol; 2004 Mar; 78(6):2984-93. PubMed ID: 14990717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High mobility group I (Y) proteins bind HIPK2, a serine-threonine kinase protein which inhibits cell growth.
    Pierantoni GM; Fedele M; Pentimalli F; Benvenuto G; Pero R; Viglietto G; Santoro M; Chiariotti L; Fusco A
    Oncogene; 2001 Sep; 20(43):6132-41. PubMed ID: 11593421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homeodomain-interacting protein kinase 2 regulates DNA damage response through interacting with heterochromatin protein 1γ.
    Akaike Y; Kuwano Y; Nishida K; Kurokawa K; Kajita K; Kano S; Masuda K; Rokutan K
    Oncogene; 2015 Jun; 34(26):3463-73. PubMed ID: 25151962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axin stimulates p53 functions by activation of HIPK2 kinase through multimeric complex formation.
    Rui Y; Xu Z; Lin S; Li Q; Rui H; Luo W; Zhou HM; Cheung PY; Wu Z; Ye Z; Li P; Han J; Lin SC
    EMBO J; 2004 Nov; 23(23):4583-94. PubMed ID: 15526030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homeodomain-interacting protein kinase 2 (HIPK2) targets beta-catenin for phosphorylation and proteasomal degradation.
    Kim EA; Kim JE; Sung KS; Choi DW; Lee BJ; Choi CY
    Biochem Biophys Res Commun; 2010 Apr; 394(4):966-71. PubMed ID: 20307497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of homeodomain-interacting protein kinase 2 on the aorta-gonad-mesonephros hematopoiesis.
    Ohtsu N; Nobuhisa I; Mochita M; Taga T
    Exp Cell Res; 2007 Jan; 313(1):88-97. PubMed ID: 17064687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Covalent modification of the homeodomain-interacting protein kinase 2 (HIPK2) by the ubiquitin-like protein SUMO-1.
    Kim YH; Choi CY; Kim Y
    Proc Natl Acad Sci U S A; 1999 Oct; 96(22):12350-5. PubMed ID: 10535925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arsenic-Induced Activation of the Homeodomain-Interacting Protein Kinase 2 (HIPK2) to cAMP-Response Element Binding Protein (CREB) Axis.
    Hashimoto K; Tsuji Y
    J Mol Biol; 2017 Jan; 429(1):64-78. PubMed ID: 27884605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PML is required for homeodomain-interacting protein kinase 2 (HIPK2)-mediated p53 phosphorylation and cell cycle arrest but is dispensable for the formation of HIPK domains.
    Möller A; Sirma H; Hofmann TG; Rueffer S; Klimczak E; Dröge W; Will H; Schmitz ML
    Cancer Res; 2003 Aug; 63(15):4310-4. PubMed ID: 12907596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.